What is the Rheos® Hypertension Pivotal Trial and who is sponsoring it?
CVRx, Inc. is sponsoring the Rheos Hypertension Pivotal Trial. This clinical trial for an alternative hypertension treatment will evaluate the safety and effectiveness of the Rheos High Blood Pressure Treatment System® Baroreflex Hypertension Therapy™ System. Up to 50 clinical sites will be involved in the study and 300 patients are being enrolled. Patients that have high blood pressure that cannot be controlled with medications and lifestyle changes are potential candidates for the study. For more study information go to www.cvrx.com.
